November 22, 2019November 20, 2019
Caregivers’ Priorities Shift During the Holidays
Columns, Treading Dark Waters - a Column by Ray Burow
Some of us are still adjusting to writing 2019 on bank checks, and here we are knocking on the ... Read more
November 22, 2019November 22, 2019
Enrollment Complete for Clinical Trial of LymPro, an Alzheimer’s Investigational Blood Diagnostic Test
News
The second part of a clinical study evaluating the use of a blood diagnostic test for Alzheimer’s disease — ... Read more
November 20, 2019November 20, 2019
$1.34M Grant Will Be Used to Broaden Psychosocial Research into Dementia Care
News
The National Institutes of Health (NIH) has awarded the Alzheimer’s Association $1.34 million to find more evidence-based ways to enhance ... Read more
November 19, 2019November 19, 2019
UW Scientist Awarded $17.2M Grant to Study Link Between Eye Health and Alzheimer’s
News
A team led by a University of Washington (UW) School of Medicine scientist will use a $17.2 million National ... Read more
November 18, 2019November 18, 2019
Antioxidant Compound, with Aid of Baker’s Yeast, May Offer Oral Supplement to Offset Alzheimer’s
News
A natural compound with antioxidative properties that might help to delay the onset of neurodegenerative diseases like Alzheimer’s can ... Read more
November 15, 2019November 13, 2019
Veterans with Brain Injuries or PTSD Face a Greater Risk of Alzheimer’s Disease
Columns, Treading Dark Waters - a Column by Ray Burow
Veterans Day has come and gone in the U.S. for another year. Proving that we’re a grateful nation, it ... Read more
November 15, 2019November 15, 2019
Humana and Seniorlink Offering Tech-Enabled Coaching to Dementia Caregivers
News
Expanding their existing relationship, Seniorlink and Humana are offering a program that provides additional care management and support to families ... Read more
November 13, 2019November 13, 2019
Study into Way of Detecting Alzheimer’s via Eye Scans Goal of Optina Diagnostics, Wagner Center Partnership
News
Laying the foundation for what could be a pivotal clinical trial into Alzheimer’s (AD) detection, Optina Diagnostics and Wagner Macula & ... Read more
November 12, 2019November 12, 2019
Neflamapimod Fails to Improve Memory But Shows Impact on Tau Levels in Phase 2b Study, EIP Pharma Announces
News
A Phase 2b study of oral neflamapimod in treating mild Alzheimer’s disease met its secondary goals of statistically significant drops in ... Read more
November 8, 2019November 13, 2019
Why National Alzheimer’s Awareness Month Matters
Columns, Treading Dark Waters - a Column by Ray Burow
In 1983, U.S. President Ronald Reagan designated November as National Alzheimer’s Awareness Month. Coincidentally, 11 years later, Reagan was ... Read more
November 8, 2019November 8, 2019
Vaccine Decreases Tau Tangles, Improves Memory and Motor Function in Mouse Model of Alzheimer’s, Study Says
News
An experimental vaccine targeting the toxic form of tau protein reduced cellular tangles in the brain — a hallmark ... Read more
November 6, 2019November 6, 2019
$15M Investment Helps Secure Funding for Phase 2 Trial of T3D-959 for Alzheimer’s
News
T3D Therapeutics has secured the needed funding to move forward with its Phase 2 trial testing T3D-959 as a ... Read more

November 22, 2019November 20, 2019

Caregivers’ Priorities Shift During the Holidays

Columns, Treading Dark Waters - a Column by Ray Burow

Some of us are still adjusting to writing 2019 on bank checks, and here we are knocking on the door of the holidays. The older we become, the faster ... Read more

November 22, 2019November 22, 2019

Enrollment Complete for Clinical Trial of LymPro, an Alzheimer’s Investigational Blood Diagnostic Test

News

The second part of a clinical study evaluating the use of a blood diagnostic test for Alzheimer’s disease — called the Lymphocyte Proliferation Test (LymPro Test) — is now fully ... Read more

November 20, 2019November 20, 2019

$1.34M Grant Will Be Used to Broaden Psychosocial Research into Dementia Care

News

The National Institutes of Health (NIH) has awarded the Alzheimer’s Association $1.34 million to find more evidence-based ways to enhance care and support for those with Alzheimer’s disease (AD) or other ... Read more

November 19, 2019November 19, 2019

UW Scientist Awarded $17.2M Grant to Study Link Between Eye Health and Alzheimer’s

News

A team led by a University of Washington (UW) School of Medicine scientist will use a $17.2 million National Institute on Aging (NIA) grant to study whether degenerative eye diseases ... Read more

November 18, 2019November 18, 2019

Antioxidant Compound, with Aid of Baker’s Yeast, May Offer Oral Supplement to Offset Alzheimer’s

News

A natural compound with antioxidative properties that might help to delay the onset of neurodegenerative diseases like Alzheimer’s can now be produced in baker’s yeast, a study reports. This ... Read more

November 15, 2019November 13, 2019

Veterans with Brain Injuries or PTSD Face a Greater Risk of Alzheimer’s Disease

Columns, Treading Dark Waters - a Column by Ray Burow

Veterans Day has come and gone in the U.S. for another year. Proving that we’re a grateful nation, it was punctuated with speeches by dignitaries and pride-filled social media ... Read more

November 15, 2019November 15, 2019

Humana and Seniorlink Offering Tech-Enabled Coaching to Dementia Caregivers

News

Expanding their existing relationship, Seniorlink and Humana are offering a program that provides additional care management and support to families caring for individuals with dementia, including Alzheimer’s disease. The dementia management ... Read more

November 13, 2019November 13, 2019

Study into Way of Detecting Alzheimer’s via Eye Scans Goal of Optina Diagnostics, Wagner Center Partnership

News

Laying the foundation for what could be a pivotal clinical trial into Alzheimer’s (AD) detection, Optina Diagnostics and Wagner Macula & Retina Center will collaborate on a “real-world” study aimed at ... Read more

November 12, 2019November 12, 2019

Neflamapimod Fails to Improve Memory But Shows Impact on Tau Levels in Phase 2b Study, EIP Pharma Announces

News

A Phase 2b study of oral neflamapimod in treating mild Alzheimer’s disease met its secondary goals of statistically significant drops in phospho-tau and tau protein levels in the cerebrospinal fluid (CSF) ... Read more

November 8, 2019November 13, 2019

Why National Alzheimer’s Awareness Month Matters

Columns, Treading Dark Waters - a Column by Ray Burow

In 1983, U.S. President Ronald Reagan designated November as National Alzheimer’s Awareness Month. Coincidentally, 11 years later, Reagan was diagnosed with Alzheimer’s. The 40th U.S. president revealed his fate ... Read more